Fool.com
The World's Greatest Investing Community
Results 61 - 70 of 1582 : Previous 3 4 5 6 7 8 9 10 11 Next
Come On -- They Represent Your Mom!
A fight with AARP proves that we're seeing politics as usual.
Pharma Researchers Need a Cure
As the industry changes, Pharmaceutical Product Development and Parexel International struggle.
Go inside the numbers on insider buying and selling.
Saved by Emerging Markets. Sort Of.
GlaxoSmithKline's top line looks good, but the bottom is what counts.
A Superstar Stock-Picker Moves to Bonds
Will Fairholme's new bond fund sink or swim?
Half-Price Sale on 3 Great Stocks
Dollar bills for sale: Fifty cents apiece.
Pfizer's and Merck's Loss Is These Companies' Gain
Too busy integrating to take advantage of additional acquisitions.
Small Market, Small Acquisition, Still a Good Move
BioMarin does everything small.
These are the right stocks for your retirement accounts.
For Tysabri, 23 Is 10 Too Many
The side effect rate is important.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK